Status:
UNKNOWN
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome
Lead Sponsor:
Shalvata Mental Health Center
Conditions:
Tourette's Syndrome
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This is an open study.approximately 20 patients diagnosed with tourette's syndrome and under pharmAcological or psychotherapy treatments will participate.patients will be recruited from Schneider hosp...
Detailed Description
Tourette's syndrome is a developmental neuropsychiatric disorder which is characterized by stereotypical motor and verbal bursts that are called Tics. There is a small number of treatments that are a...
Eligibility Criteria
Inclusion
- Men and woman between the ages of 18-55
- Diagnosed as suffering from tourette's syndrome according to the DSM IV, as determined by a senior psychiatrist on the basis of the Structured Clinical Interview for DSM-IV Axis I
- pharmocological treatment stays constant for the duration of the study
- Gave informed consent for participation in the study
Exclusion
- Electroconvulsive therapy (ECT) less than 9 months prior to screening.
- Attempted suicide in the past year.
- History of seizure or heat convulsion.
- History of epilepsy or seizure in first degree relatives.
- History of head injury.
- History of any metal in the head (outside the mouth).
- Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, surgical clips or any medical pumps.
- History of frequent or severe headaches.
- History of migraine.
- History of hearing loss.
- Known history of cochlear implants
- Pregnancy or not using a reliable method of birth control.
- Inadequate communication with the patient.
- Under custodial care.
- Participation in current clinical study or clinical study within 30 days prior to this study.
- A significant physical illness which is not balanced.
- an addiction to psychoactive drugs in the last year or psychoactive substance abuse in the last month without addiction.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00965211
Start Date
September 1 2009
End Date
January 1 2013
Last Update
January 5 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shalvata Mental Health Center
Hod HaSharon, Israel
2
Shalvata Mental Health Center
Hod HaSharon, Israel